{"id":"W4386319418","doi":"10.1016/j.bulcan.2023.06.009","title":"Real-world dostarlimab use in advanced/recurrent endometrial cancer in France","year":2023,"lang":"en","type":"article","venue":"Bulletin du Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Sierra Oncology; GlaxoSmithKline","keywords":"Medicine; Endometrial cancer; Expanded access; Clinical trial; Internal medicine; Cancer; Authorization; Randomized controlled trial; Cohort; Adverse effect; Oncology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032602,0.0003397372,0.0007818005,0.001121099,0.00005433421,0.00003360704,0.0001743189,0.0001204078,0.005808847],"category_scores_gemma":[0.0004543846,0.000294937,0.0001745152,0.004385162,0.00007297518,0.00009032212,0.0001104558,0.0004278041,0.0003179074],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001021367,"about_ca_system_score_gemma":0.000245757,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02287042,"about_ca_topic_score_gemma":0.01268384,"domain_scores_codex":[0.9972111,0.00009730211,0.0006411428,0.0007008117,0.0005794657,0.0007701711],"domain_scores_gemma":[0.9986355,0.0005330603,0.000143471,0.0003537811,0.0001072258,0.0002269773],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003688699,0.000476567,0.8535092,0.0001922377,0.00009656232,0.0005162202,0.000215722,0.0007584299,0.0003985717,0.0001017893,0.009309744,0.1307362],"study_design_scores_gemma":[0.01967945,0.0002406667,0.6500933,0.0007553042,0.00005470606,0.000002188706,0.00003748988,0.00007950624,0.0006084184,0.00004538518,0.3281011,0.0003024644],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.979659,0.005966811,0.00000235253,0.007573131,0.002395398,0.001342215,0.000269145,0.0001875403,0.002604375],"genre_scores_gemma":[0.9429588,0.04215492,0.0002099463,0.001110265,0.001194265,0.002111471,0.00007209298,0.00008787038,0.01010032],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3187914,"threshold_uncertainty_score":0.9999503,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03287550597304283,"score_gpt":0.3279943623960584,"score_spread":0.2951188564230156,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}